Isoleucine–tRNA ligase, cytoplasmic

IARS1
Identifiers
AliasesIARS1, isoleucyl-tRNA synthetase 1, ILERS, isoleucyl-tRNA synthetase, PRO0785, GRIDHH, IRS, ILRS, IARS
External IDsOMIM: 600709; MGI: 2145219; GeneCards: IARS1
Enzyme activity
EC #BRENDAExPASyKEGGMetaCyc
6.1.1.5↗↗↗↗
Orthologs
DatabasesNCBI: entry; OMA: entry
SpeciesHumanMouse
Entrez
Ensembl
UniProt
RefSeq (mRNA)

NM_002161
NM_013417
NM_001374299
NM_001374300
NM_001374301

NM_172015

RefSeq (protein)

NP_742012

Location (UCSC)Chr 9: 92.21 – 92.29 MbChr 13: 49.84 – 49.89 Mb
PubMed search
Wikidata
View/Edit HumanView/Edit Mouse

Isoleucine–tRNA ligase, cytoplasmic, also called isoleucyl-tRNA synthetase, cytoplasmic, is an enzyme that in humans is encoded by the IARS1 gene (previously IARS). Like the related enzyme, IARS2, this enzyme functions as an isoleucine–tRNA ligase, meaning it attaches the amino acid isoleucine to its corresponding transfer RNA (tRNAIle) as part of protein synthesis.

Aminoacyl-tRNA synthetases catalyze the aminoacylation of tRNA by their cognate amino acid. Because of their central role in linking amino acids with nucleotide triplets contained in tRNAS, aminoacyl-tRNA synthetases are thought to be among the first proteins that appeared in evolution. Isoleucine-tRNA synthetase belongs to the class-I aminoacyl-tRNA synthetase family and has been identified as a target of autoantibodies in the autoimmune disease polymyositis/dermatomyositis. Two alternatively spliced variants have been isolated that represent alternate 5' UTRs.

Interactions

IARS has been shown to interact with EPRS.

Medical significance

Pathogenic mutations in IARS1 (compound heterozygous) are the cause of a disorder associated with impaired physical and intellectual development, and sometimes liver disfunction, called GRIDHH (growth retardation, impaired intellectual development, hypotonia, and hepatopathy).